J Virol. 2008 Jul;82(13):6762-6. Epub 2008 Apr 23.

Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.

Bandaranayake RM, Prabu-Jeyabalan M, Kakizawa J, Sugiura W, Schiffer CA.

Source

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605, USA.

Abstract

The effect of amino acid variability between human immunodeficiency virus type 1 (HIV-1) clades on structure and the emergence of resistance mutations in HIV-1 protease has become an area of significant interest in recent years. We determined the first crystal structure of the HIV-1 CRF01_AE protease in complex with the p1-p6 substrate to a resolution of 2.8 A. Hydrogen bonding between the flap hinge and the protease core regions shows significant structural rearrangements in CRF01_AE protease compared to the clade B protease structure.

PMID:: 18434392; [PubMed - indexed for MEDLINE]
PMCID:: PMC2447101

Free PMC Article

Images from this publication.See all images (2) Free text

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. [Virology. 1996]
Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA, Perez EE, Lamers SL, Farmerie WG, Dunn BM, Sleasman JW, Goodenow MM. Virology. 1996 May 15; 219(2):407-16.
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways. [J Virol. 2010]
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.
Bandaranayake RM, Kolli M, King NM, Nalivaika EA, Heroux A, Kakizawa J, Sugiura W, Schiffer CA. J Virol. 2010 Oct; 84(19):9995-10003. Epub 2010 Jul 21.
Impact of amino acid variations in Gag and protease of HIV type 1 CRF01_AE strains on drug susceptibility of virus to protease inhibitors. [J Acquir Immune Defic Syndr. 2...]
Impact of amino acid variations in Gag and protease of HIV type 1 CRF01_AE strains on drug susceptibility of virus to protease inhibitors.
Jinnopat P, Isarangkura-na-ayuthaya P, Utachee P, Kitagawa Y, de Silva UC, Siripanyaphinyo U, Kameoka Y, Tokunaga K, Sawanpanyalert P, Ikuta K, et al. J Acquir Immune Defic Syndr. 2009 Nov 1; 52(3):320-8.
Review Design of tight-binding human immunodeficiency virus type 1 protease inhibitors. [Methods Enzymol. 1994]
Review Design of tight-binding human immunodeficiency virus type 1 protease inhibitors.
Vacca JP. Methods Enzymol. 1994; 241:311-34.
Review Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease. [Methods Enzymol. 1994]
Review Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease.
Kempf DJ. Methods Enzymol. 1994; 241:334-54.

See reviews... See all...

Cited by 3 PubMed Central articles

Role of Gag in HIV Resistance to Protease Inhibitors. [Viruses. 2010]
Role of Gag in HIV Resistance to Protease Inhibitors.
Clavel F, Mammano F. Viruses. 2010 Jul; 2(7):1411-26. Epub 2010 Jul 5.
Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility. [J Am Chem Soc. 2009]
Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility.
Kear JL, Blackburn ME, Veloro AM, Dunn BM, Fanucci GE. J Am Chem Soc. 2009 Oct 21; 131(41):14650-1.
New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors. [Curr Opin HIV AIDS. 2008]
New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors.
Nalam MN, Schiffer CA. Curr Opin HIV AIDS. 2008 Nov; 3(6):642-6.

Structures reported by this article

Crystal Structure Of Hiv-1 Crf01_ae In Complex With The Substrate P1-P6

PDB: 3D3T

Source: Human immunodeficiency virus 1, synthetic construct

Method: X-Ray Diffraction

Resolution: 2.8 Å

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Taxonomy via GenBank
Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
Protein
Protein translation features of primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
Structure
Three-dimensional structure records in the NCBI Structure database for data reported in the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in ...
Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.
J Virol. 2008 Jul ;82(13):6762-6. Epub 2008 Apr 23 .

PubMed
Chronic beryllium disease: risk from low-level exposure.
Chronic beryllium disease: risk from low-level exposure.
Am J Respir Crit Care Med. 2008 May 1 ;177(9):936-7.

PubMed
O-glucosylation and O-fucosylation occur together in close proximity on the firs...
O-glucosylation and O-fucosylation occur together in close proximity on the first epidermal growth factor repeat of AMACO (VWA2 protein).
J Biol Chem. 2008 Jun 27 ;283(26):17846-54. Epub 2008 Apr 23 .

PubMed
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its ...
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.
J Biol Chem. 2008 Jul 11 ;283(28):19192-200. Epub 2008 Apr 23 .

PubMed
Violent behaviour among people with schizophrenia: a framework for investigation...
Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention.
Philos Trans R Soc Lond B Biol Sci. 2008 Aug 12 ;363(1503):2505-18.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Structures reported by this article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information